Smith Geoffrey Wade
SEC CIK 1418239 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | Dir | 20.9K | — | — | 5 | 2023-01-26 | 2023-07-20 |
Most active insiders at OBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sherman Darren | See Remarks, Dir | $10.7K | $257.6K |
| 2 | Hochman David P | See Remarks, Dir | $149.2K | — |
| 3 | Fain Eric S | Dir | $82.6K | — |
| 4 | Aryeh Jason | Dir | $37.5K | — |
| 5 | RTW INVESTMENTS, LP | 10% | — | $132.16 |
| 6 | Cleary Chris | Dir | — | — |
| 7 | Mack John Prosper | Dir | — | — |
| 8 | Aiello Joshua | Principal Accounting Off | — | — |
| 9 | Connealy Pamela Ann | Dir | — | — |
| 10 | Taylor Andrew Lawrence | CFO | — | — |
Smith Geoffrey Wade made no open-market trades at OBIO in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-24 | 2023-07-20 | OBIO | Orchestra BioMed Holdings, Inc. | Smith Geoffrey Wade | Dir | A - Grant | $0.00 | +16.7K | 20.9K | +393% | $0 | |
| DMI | 2023-05-08 | 2023-04-12 | OBIO | Orchestra BioMed Holdings, Inc. | Smith Geoffrey Wade | Dir | M - OptEx | — | +327.6K | 245.1K | New | — |
| D | 2023-05-08 | 2023-04-12 | OBIO | Orchestra BioMed Holdings, Inc. | Smith Geoffrey Wade | Dir | M - OptEx | — | +758 | 4,246 | +22% | — |
| D | 2023-01-30 | 2023-01-26 | OBIO | Orchestra BioMed Holdings, Inc. | Smith Geoffrey Wade | Dir | A - Grant | — | +3,488 | 3,488 | New | — |
| DMI | 2023-01-30 | 2023-01-26 | OBIO | Orchestra BioMed Holdings, Inc. | Smith Geoffrey Wade | Dir | A - Grant | — | +1.51M | 201.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations